Bristol-Myers Agrees To Clean Air Act Upgrades
Bristol-Myers Squibb Co., the New York-based pharmaceutical manufacturer, has agreed to resolve alleged violations of the Clean Air Act by reducing the output of ozone-depleting refrigerants at five industrial facilities at...To view the full article, register now.
Already a subscriber? Click here to view full article